Determination of mitomycin C, 2,7-diaminomitosene, 1,2-cis- and 1,2-trans-1-hydroxy-2,7-diaminomitosene in tumour tissue by high-performance liquid chromatography
- 29 January 1993
- journal article
- Published by Elsevier BV in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 612 (1), 105-113
- https://doi.org/10.1016/0378-4347(93)80373-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Keynote address: Bioreductive mechanismsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H:(quinone-acceptor)oxidoreductaseCancer Chemotherapy and Pharmacology, 1988
- Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female ratsGynecologic Oncology, 1986
- Autocatalytic quinone methide formation from mitomycin cBiochemistry, 1986
- Pharmacokinetics of Mitomycin C in Dogs: Application of a High-Performance Liquid Chroma tograp h ic AssayJournal of Pharmaceutical Sciences, 1984
- Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lungCancer Chemotherapy and Pharmacology, 1984
- Pharmacokinetics of mitomycin C in rabbit and humanCancer Chemotherapy and Pharmacology, 1982
- High-performance liquid chromatographic determination of the antitumor agent mitomycin c in human blood plasmaAnalytica Chimica Acta, 1981
- Bioactivation as a Model for Drug Design Bioreductive AlkylationScience, 1977
- Mitomycins and Porfiromycin: Chemical Mechanism of Activation and Cross-linking of DNAScience, 1964